We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Absolute Antibody Receives ISO 9001:2015 Certification for Recombinant Antibody Manufacturing Facility

Image credit: Absolute Antibody

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Absolute Antibody Receives ISO 9001:2015 Certification for Recombinant Antibody Manufacturing Facility"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Absolute Antibody Ltd., an industry-leading manufacturer of recombinant antibodies, announces its manufacturing facility based in Wilton Centre, Redcar, England has been certified under ISO 9001:2015 as of December 17, 2018. The newly expanded, state-of-the-art facility was designed with a focus on the standards to provide customers and distributors with the highest level of quality. International Organization for Standardization (ISO) 9001:2015 is the most updated standard of its kind, and its globally recognized guidelines for manufacturing facilities specify requirements for quality systems, feedback data management and controlled manufacturing processes to ensure safe, reliable products.

The ISO 9001:2015 certification strengthens Absolute Antibody’s diagnostic offerings, which enable customers worldwide to use antibody sequencing, engineering and expression services to develop superior diagnostic assays. The company’s recombinant antibody technology delivers highly reliable antibodies in any format, ideal for diagnostic developers as well as researchers working in pharmaceuticals, biotechnology and academia.

“Receipt of our ISO 9001:2015 certification demonstrates our company’s commitment to our customer base,” said Dr. Nicholas Hutchings, founder and CEO of Absolute Antibody. “Our goal has always been to deliver the highest level of quality and customer satisfaction. We are proud to have an excellent quality management system (QMS) in place to measure and monitor for consistent outcomes, which will increase our efficiency and productivity, furthering our capabilities to offer antibodies for the diagnostics market.”

This past year, Absolute Antibody merged with Boston-based Kerafast, Inc. to expand their product and service portfolio and to provide more efficient delivery to its large North American customer base. Fueled by the recent increase in adoption of recombinant antibody technology, the company has grown significantly, and adherence to ISO 9001:2015 guidelines will enable Absolute Antibody to continue to expand its catalog and custom service offerings.